Qing‐Hai Ye

10.8k total citations · 3 hit papers
126 papers, 8.2k citations indexed

About

Qing‐Hai Ye is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Qing‐Hai Ye has authored 126 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hepatology, 47 papers in Molecular Biology and 45 papers in Oncology. Recurrent topics in Qing‐Hai Ye's work include Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and MicroRNA in disease regulation (15 papers). Qing‐Hai Ye is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and MicroRNA in disease regulation (15 papers). Qing‐Hai Ye collaborates with scholars based in China, United States and Ethiopia. Qing‐Hai Ye's co-authors include Lun–Xiu Qin, Hu‐Liang Jia, Xin Wei Wang, Anuradha Budhu, Marshonna Forgues, Zhao–You Tang, Qiongzhu Dong, Ning Ren, Junfang Ji and Taro Yamashita and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Qing‐Hai Ye

124 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features

2008 958 citations Taro Yamashita, Junfang Ji et al. Gastroenterology profile →
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma

2008 577 citations Taro Yamashita, Marshonna Forgues et al. Cancer Research profile →
Identification of metastasis-related microRNAs in hepatocellular carcinoma

2008 574 citations Anuradha Budhu, Hu‐Liang Jia et al. Hepatology profile →

Peers

Countries citing papers authored by Qing‐Hai Ye

Since Specialization

Citations

This map shows the geographic impact of Qing‐Hai Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing‐Hai Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing‐Hai Ye more than expected).

Fields of papers citing papers by Qing‐Hai Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing‐Hai Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing‐Hai Ye. The network helps show where Qing‐Hai Ye may publish in the future.

Co-authorship network of co-authors of Qing‐Hai Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Qing‐Hai Ye. A scholar is included among the top collaborators of Qing‐Hai Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing‐Hai Ye. Qing‐Hai Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition 2025 ·Science Advances ·(unknown), Mincheng Yu, Peiyi Xie, (unknown), (unknown), Wenxin Xu, Xian Li, Mengyuan Wu, Zihao Zhang, Zheng Chen, Yong‐Sheng Xiao, Jian Zhou, Jia Fan, Mien‐Chie Hung, (unknown), (unknown), Qing‐Hai Ye, (unknown)	0
2	Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma 2025 ·Gut ·(unknown), (unknown), Jialei Weng, Mincheng Yu, Qiang Yu, Peiyi Xie, Shaoqing Liu, (unknown), Bo Zhang, (unknown), Yong‐Sheng Xiao, Hui‐Chuan Sun, Qing‐Hai Ye, (unknown)	1
3	ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis 2024 ·Cancer Research ·Peiyi Xie, (unknown), (unknown), (unknown), Mincheng Yu, (unknown), Mengyuan Wu, (unknown), Min Xu, Xiao‐Dong Zhu, (unknown), (unknown), Cheng Huang, Jian Zhou, Jia Fan, Mien‐Chie Hung, Hui‐Chuan Sun, Qing‐Hai Ye, (unknown), (unknown)	11
4	SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion 2024 ·OncoImmunology ·Zheng Chen, Mincheng Yu, Bo Zhang, Jin Lei, Qiang Yu, Shuang Liu, Binghai Zhou, Jiuliang Yan, (unknown), Xiaoqiang Li, Yongfeng Xu, Yong‐Sheng Xiao, Jian Zhou, Jia Fan, Mien‐Chie Hung, Qing‐Hai Ye, Hui Li, Lei Guo	3
5	Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study 2023 ·International Journal of Surgery ·Wenju Chang, Yijiao Chen, (unknown), Li Ren, Yuqiu Xu, Dexiang Zhu, Wentao Tang, Qing‐Hai Ye, Xiaoying Wang, (unknown), Ye Wei, Jianmin Xu	2
6	CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner 2023 ·Journal of Gastrointestinal Oncology ·Lei Jin, Ju Huang, Lei Guo, Bo Zhang, Qin Li, Hui Li, Mincheng Yu, Peiyi Xie, Qiang Yu, Zheng Chen, Shuang Liu, Yongfeng Xu, Yong‐Sheng Xiao, Ming Lu, Qing‐Hai Ye	6
7	Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma 2019 ·Cancer Research ·Atsushi Takai, Hien Dang, Naoki Oishi, Subreen A. Khatib, Sean P. Martin, Dana A. Dominguez, Ji Luo, Rachel Bagni, Xiaolin Wu, Katie Powell, Qing‐Hai Ye, Hu‐Liang Jia, Lun–Xiu Qin, Jinqiu Chen, (unknown), Xiaoling Luo, Snorri S. Thorgeirsson, Xin Wei Wang	23
8	MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1 2019 ·Gastroenterology ·Hui Li, Chia‐Wei Li, Xiaoqiang Li, Qingqing Ding, (unknown), Shuang Liu, Chunxiao Liu, Chien‐Chen Lai, Jung-Mao Hsu, Qiongzhu Dong, Weiya Xia, Jennifer L. Hsu, Hirohito Yamaguchi, Yi Du, Yun‐Ju Lai, Xian Wen Sun, Paul Koller, Qing‐Hai Ye, Mien‐Chie Hung	154
9	Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma 2013 ·Clinical Cancer Research ·Wenwei Zhu, (unknown), Lei Guo, Hu‐Liang Jia, (unknown), Jubo Zhang, Christopher A. Loffredo, Marshonna Forgues, Hua Huang, (unknown), Ning Ren, Qiongzhu Dong, Haijun Zhou, Zhenggang Ren, Naiqing Zhao, Xin Wei Wang, Zhao–You Tang, Lun–Xiu Qin, Qing‐Hai Ye	111
10	Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases 2013 ·Journal of Clinical Oncology ·Lechi Ye, Tianshu Liu, Li Ren, Ye Wei, Dexiang Zhu, (unknown), Qing‐Hai Ye, Yiyi Yu, Bo Xu, Xinyu Qin, Jianmin Xu	296
11	Postoperative Serum Osteopontin Level is a Novel Monitor for Treatment Response and Tumor Recurrence after Resection of Hepatitis B–related Hepatocellular Carcinoma 2012 ·Annals of Surgical Oncology ·Chuang Zhou, Haijun Zhou, Xiaofei Zhang, (unknown), Qing‐Hai Ye, Yan Zheng, Ji Wang, Haitao Zhu, Qiongzhu Dong, Hu‐Liang Jia, Wenwei Zhu, (unknown), Yue Zhao, Dongmei Gao, Lun–Xiu Qin	23
12	Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma 2012 ·Hepatology ·Qiongzhu Dong, (unknown), Yue Zhao, Hu‐Liang Jia, Haijun Zhou, Chun Dai, Haijing Sun, Yi Qin, (unknown), Ning Ren, Qing‐Hai Ye, Lun–Xiu Qin	55
13	Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma 2011 ·Cancer Research ·Ning Ren, Jincai Wu, Qiongzhu Dong, Haijing Sun, Hu‐Liang Jia, Guocai Li, Bingsheng Sun, Chun Dai, Jiong Shi, Jinwang Wei, Yuan‐Yuan Sheng, Haijun Zhou, Qing‐Hai Ye, Lun–Xiu Qin	17
14	Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient Survival 2011 ·Gastroenterology ·Stéphanie Roessler, (unknown), Anuradha Budhu, Yidong Chen, Xuelian Zhao, Junfang Ji, Robert L. Walker, Hu‐Liang Jia, Qing‐Hai Ye, Lun–Xiu Qin, Zhao–You Tang, Ping He, Kent W. Hunter, Snorri S. Thorgeirsson, Paul S. Meltzer, Xin Wei Wang	248
15	Expression and prognostic significance of osteopontin and caspase‐3 in hepatocellular carcinoma patients after curative resection 2010 ·Cancer Science ·Hua Huang, (unknown), (unknown), Yuhua Xue, Qiongzhu Dong, Qing‐Hai Ye, Lun–Xiu Qin	51
16	EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma breakdown → 2008 ·Cancer Research ·Taro Yamashita, Marshonna Forgues, Wei Wang, Jin Woo Kim, Qing‐Hai Ye, Hu‐Liang Jia, Anuradha Budhu, Krista A. Zanetti, Yidong Chen, Lun–Xiu Qin, Zhao–You Tang, Xin Wei Wang	577
17	[Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]. 2008 ·PubMed ·Hu‐Liang Jia, (unknown), Qing‐Hai Ye, Lun–Xiu Qin	4
18	EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features breakdown → 2008 ·Gastroenterology ·Taro Yamashita, Junfang Ji, Anuradha Budhu, Marshonna Forgues, Wen Yang, Hong‐Yang Wang, Hu‐Liang Jia, Qing‐Hai Ye, Lun–Xiu Qin, (unknown), Lola M. Reid, Hiroshi Minato, Masao Honda, Shuichi Kaneko, Zhao–You Tang, Xin Wei Wang	958
19	Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma 2007 ·Clinical Cancer Research ·Hu‐Liang Jia, Qing‐Hai Ye, Lun–Xiu Qin, Anuradha Budhu, Marshonna Forgues, Yidong Chen, Yinkun Liu, Hui‐Chuan Sun, Lu Wang, Hongzhou Lu, (unknown), Zhao–You Tang, Xin Wei Wang	169
20	The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma 2006 ·Journal of Cancer Research and Clinical Oncology ·Hui Zhang, Qing‐Hai Ye, Ning Ren, Lei Zhao, Yanfang Wang, Xin Wu, Hui‐Chuan Sun, Lu Wang, Boheng Zhang, Yinkun Liu, Zhao–You Tang, Lun–Xiu Qin	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact